Abstract Zika virus (ZIKV) is an arthropod-borne arbovirus from the family Flaviviridae, which has been recently confirmed to cause severe neurological abnormalities (such as microcephaly, brain parenchymal calcification, hydrocephalus, and malformations of cortical development) in the infected fetuses. The Placenta plays a multifold role in prenatally acquired ZIKV infection. It serves as a port of virus transmission to the fetus, and also can be directly affected by ZIKV leading to a diminished fetal blood supply or a disrupted/changed biological mediators' synthesis. It is crucial to have a detailed knowledge about these pathomechanisms for preventing virus transmission in the infected pregnant women, as well as for prohibiting or reversing placental changes.
Introduction
Zika virus (ZIKV) is a mosquito-borne single-stranded ribonucleic acid arbovirus, and a member of the family Flaviviridae. The virus was first identified in Uganda in 1947 in rhesus monkeys. The first human infection by ZIKV was reported in Nigeria in 1954. ZIKV had no significant impact on public health for decades, and it was limited to the African and Asian nations. In 2007, however, the virus was reported outside Africa and Asia during an outbreak in the Pacific Islands. Subsequently, a serious ZIKV epidemic began in Brazil in early 2015, which outspread rapidly throughout the South American and Caribbean countries. More importantly, a causal relationship between prenatally acquired ZIKV infection and neonatal microcephaly has been confirmed during the recent outbreak in South America [9] .
Incubation period of postnatally acquired ZIKV infection is between a few days and 2 weeks. Most of adult patients are asymptomatic, and about 20% of them show mild symptoms including low-grade fever, maculopapular rash, arthralgia, myalgia, headache, conjunctivitis, pruritus, and vomiting. The symptomatic course lasts for a few days to 1 week. ZIKV may also cause autoimmune neurologic complications such as Guillain-Barré syndrome and acute disseminated encephalomyelitis in the infected adults on rare occasions [10] .
ZIKV infection is less benign in the prenatal period, and can lead to severe fetal abnormalities (called as congenital Zika syndrome) in about 1-13% of pregnant women infected during the first trimester. Maternal infection during the early pregnancy has been associated with stillbirth, miscarriage, fetal growth restriction, fetal central nervous system (CNS) abnormalities (particularly severe microcephaly), and ocular abnormalities [9, 10] .
Postnatally acquired ZIKV infection is horizontally transmitted by the mosquito bite (Aedes aegypti as the main vector), but other routes including sexual transmission have been reported as well. Prenatally acquired infection, on the other hand, is vertically transmitted from infected mother to fetus [9] . A detailed knowledge about the pathomechanisms of ZIKV vertical transmission and the placental changes caused by this virus is of paramount importance for preventing ZIKV transmission to the fetus, and ameliorating fetal prognosis.
Vertical transmission in animal models
ZIKV infection causes fetal abnormalities in infected pregnant primates, but the most striking fetal abnormalities has been reported in infected mice. The described fetal effects in the infected mice include: (1) fetal growth restriction; (2) microcephaly; (3) severe brain injuries; and (4) miscarriage. The viral load is very high in the placenta of the infected mice, which leads to severe placental damage and disruption of the microvascular system that in part restrict the blood supply to the fetus. These changes are most likely responsible for intrauterine growth restriction, and fetal demise [2] . In addition, ZIKV can cross the placenta barrier to infect the mice fetuses (neural progenitors as the main target cells), and disrupt the normal brain development. It has been reported that the developed placenta at late pregnancy is more resistant to ZIKV infection in the mice [3] .
Vertical transmission in the human
The increased number of neonatal neurodevelopmental defects during ZIKV outbreak, and isolation of the virus from cerebral tissue of the aborted fetuses suggest vertical transmission of the virus as the main pathogenesis of fetal CNS abnormalities [9] .
The fetal prognosis depends largely on the timing of infection, since the placenta at early pregnancy has different properties compared to late pregnancy. The virus would theoretically have a more difficult access to the fetus in the late pregnancy, because it should pass through the trophoblastic cell layers, chorionic and amniotic membranes, and probably the amniotic fluid to reach the fetus [4] . In addition, primary human trophoblast, consisting of cytotrophoblast and syncytiotrophoblast, can release lambda interferon (IFN-k) during the late pregnancy which has antiviral property. IFN-k acts in autocrine and paracrine fashions, and protect trophoblastic and non-trophoblastic cells of the term placenta to become infected [7] .
Human placental macrophages (also known as Hofbauer cells), which are of fetal origin, are highly permissive to ZIKV and serve as the main target cells for ZIKV in placenta once the virus passes the trophoblastic layer. The Hofbauer cells are unequivocally permissive to ZIKV, but significant difference in the susceptibility of infected cases has been detected. Transplacental transmission of ZIKV to fetus largely relies on the Hofbauer cells ability for transplacental migration to reach the fetal vessels. In addition, the virus sheds into the placental stroma after replication in the Hofbauer cells, and can infect other placental cells (such as stromal fibroblasts) [6] .
It has been suggested that the main biologic process by which ZIKV is transmitted through the placenta may be the so-called secretory autophagy. Actually, autophagy is a defensive mechanism of the placenta to protect the fetus from pathogens by degradation of intracellular damaged components by the lysosomal enzymes (i.e., degradative autophagy). However, some pathogens can inhibit the process of degradation, and use this mechanism as a route for transferring through the placenta. In this hijacked pathomechanism (i.e., secretory autophagy), infective agents are packed within intracytoplasmic vacuoles (named as autophagosomes), and crossing the path to the fetus [11] .
Transplacental transmission of ZIKV to the fetus takes about 5 weeks, which is even longer during early pregnancy. If we eliminate ZIKV from the placenta during this window period (i.e., before the virus reaches the fetus), the incidence of congenital abnormalities would be decreased significantly. Interferon therapy, alone or in combination with the drugs that may interfere with the secretory autophagy, can be potentially beneficial for this purpose [8] .
Destructive effects on the placenta ZIKV can increase the permeability of the placenta by inducing trophoblast apoptosis and vascular damage [6] . Acute inflammatory changes and TORCH-type chronic placentitis have been reported in ZIKV infected placentas as well (although these placental changes in congenital Zika syndrome are less common compared to other TORCH infections such as congenital toxoplasmosis). The placental tissue of the affected newborns and spontaneous abortions reveal villous edema, lymphohistiocytic intervillositis, increased number of Hofbauer cells, increased fibrin deposition, and dense chorionic villi dystrophic calcification and sclerosis. These changes can cause placental function impairment, and lead to intrauterine growth restriction and fetal demise. Macroscopic abnormalities of the placenta can be detected and monitored by prenatal ultrasound examination of the placenta and umbilical cord utilizing both grayscale and Doppler methods, which are valuable for predicting the pregnancy outcome [5, 9] .
Placenta-mediated fetal brain injury
Neurotropic properties of ZIKV is widely accepted now. The virus may reach the developing brain, and induce apoptosis mainly in the neural progenitor cells. This pathomechanism has been proposed as the cause of the majority of changes that are seen in the brain of the affected fetuses/neonates. However, there may be yet another injury pathway. Theoretically, pro-inflammatory response of the placenta to the viral invasion can disrupt the embryonic brain development by releasing inflammatory mediators into the fetal circulation. In addition, ZIKV may interfere with the synthesis of some specific placental molecules, which serve important duties in the normal fetal brain development. The proposed neurotoxic effects mediated by the infected placenta can be hypothetically prohibited by reducing the viral load in the maternal blood stream, stimulating autophagy in the placenta, or reducing placental inflammatory response to the virus. These goals can be achieved pharmacologically by the development of effective antiviral agents and/or immune system stimulators/modulators [1] .
Concluding remarks
The placenta not only plays an important role in ZIKV transmission to the fetus, but also placental inflammatory and dystrophic changes caused by the virus may be responsible for poor fetal outcomes such as intrauterine growth restriction and fetal demise. Placental alterations may also directly contribute to the fetal brain injury. Considering its crucial role in ZIKV-related fetal abnormalities, placenta can be a field of further research for preventing vertical transmission of the virus in the infected pregnant women, and ameliorating fetal prognosis by prohibiting or reversing placental changes.
